|
Gerald B. Appel, M.D. - Director
Dr. Appel received his undergraduate training at Cornell University where
he graduated in three years as a member of Phi Beta Kappa. He then went to
Albert Einstein College of Medicine and was a member of the AOA honor
society. He completed three years of residency training in Internal
Medicine at Columbia Presbyterian Medical Center and then fellowships in
Nephrology at Columbia University and Yale New Haven Medical Center.
Returning to Columbia U. in 1978 he is now a Professor of Clinical Medicine
with Tenure of Title and Director of Clinical Nephrology. He has published
over 200 manuscripts and book chapters. He has served as a officer and
President of the New York Society of Nephrology, the on Medical Advisory
Boards of the New York-New Jersey branch of the National Kidney Foundation,
and as director for numerous programs for the American Society of
Nephrology and the National Kidney Foundation. He serves on the editorial
board of Up-To-Date and Clinical Journal of American Society of Nephrology (CJASN). His major
interest has been glomerular diseases including focal sclerosis, membranous
nephropathy, IgA nephropathy and lupus nephritis.
|
|
Andrew Bomback, MD, MPH – Co-Director
Dr. Andrew Bomback received his medical degree from Columbia University
College of Physicians & Surgeons. He completed residency in Internal
Medicine and fellowships in Nephrology and Clinical Epidemiology at the
University of North Carolina at Chapel Hill, where he was the Doc J.
Thurston III Fellow in Nephrology and Hypertension. In 2009, he returned to
Columbia University as an associate at the Center for Glomerular Diseases.
He is currently Assistant Professor of Clinical Medicine. Dr. Bomback has
published over 75 peer-reviewed articles and book chapters on chronic
kidney disease, with a specific focus on hypertension and glomerular
diseases. He is principal- or co-investigator of several clinical trials
evaluating novel therapies for glomerular diseases.
|
|
Jai Radhakrishnan, MD, MS
Dr. Radhakrishnan joined the faculty at Columbia Univeristy after
completing fellowships at the Massachusetts General Hospital-Harvard
Medical School and Columbia-Presbyterian Medical Center. He is currently Professor
of Medicine and Clinical Director Nephrology at Presbyterian Hospital. He
has written numerous manuscripts dealing with the therapy of glomerular
diseases and is on the Editoral Board of Kidney International and
Editor-in-Chief of Kidney International Reports. He is a co-investigator on
several on-going clinical trials dealing with glomerular diseases.
|
|
Vivette D'Agati, M.D.
Dr. Vivette D’Agati completed her undergraduate studies at Yale College and
attended medical school at Duke and New York University. She completed her
residency in Pathology and fellowship training in Renal Pathology at Columbia
Presbyterian Medical Center. Her training in renal pathology was under Dr.
Conrad Pirani, one of the true “Fathers of Renal Pathology”. She rose
through the ranks to become Professor of Pathology in 1994. During this
time, she created one of the largest laboratories of renal pathology in the
world, processing over 2700 biopsies annually. She has published over 190
original manuscripts and 40 book chapters dealing with numerous major renal
diseases. She has co-authored several renal pathology texts and served on
the editorial board of the most prestigious renal journals. She has
directed the world renowned Columbia University Postgraduate course, “Renal
Biopsy in Medical Diseases of the Kidney” for over 20 years
|
|
Glen Markowitz, M.D.
Dr. Markowitz received his undergraduate training at Brandeis
University and then graduated from Albert Einstein College of Medicine in
1994 where he was elected to the Alpha Omega Alpha honor society. After
completing his residency in Anatomic Pathology at Albert Einstein in 1997,
he came to Columbia University to train as a renal pathology fellow under
Dr. Vivette D’Agati. At the completion of his fellowship in 1998, he joined
the faculty as an Assistant Professor of Clinical Pathology at Columbia and
was promoted to Associate Professor in 2002. Dr. Markowitz is a past
recipient of the Renal Pathology Society’s Young Investigator Award. In his
seven years on faculty at Columbia, he has published 84 papers and has
played an active role in teaching medical students for which he has been a
finalist for multiple teaching awards. Dr Markowitz has played a vital role
in the expansion of the renal pathology laboratory which now processes 2700
renal biopsies per year.
|
|
Donald W. Landry, M.D.
Dr. Landry is a Professor of Medicine and Director of the Division of
Nephrology in the Department of
Medicine at Columbia University, College of Physicians & Surgeons. Dr.
Landry completed his Ph.D. in organic chemistry at Harvard University under
Nobel laureate Robert Burns Woodward in 1979 and then obtained the M.D.
degree from Columbia University in 1983. After completing his Residency in
Internal Medicine at the Massachusetts General Hospital, he returned to
Columbia University as an NIH Physician-Scientist, 1985-90. During this
period, Dr. Landry also completed subspecialty training in Nephrology. In
1991, he established a laboratory at Columbia University to investigate
medical applications of artificial enzymes. His laboratory in
Experimental Therapeutics focuses on organic chemical solutions to
intractable medical problems. His clinical research in Nephrology has
led to the discovery of a syndrome of deficiency of the hormone
vasopressin in shock, a state of low blood pressure that impairs glomerular
function.
|
|
Ali Gharavi , M.D.
Dr. Gharavi is Irving Assistant
Professor of Medicine at Columbia University. He received his undergraduate
degree from Georgetown University and his M.D. Degree at George Washington
University. He completed his residency in Internal Medicine and fellowships
in Hypertension and Nephrology at The Mount Sinai Medical Center. He next obtained post doctoral training
in genetics at Yale University. In
2003, he joined Columbia University to establish a laboratory aimed on
investigating the genetic basis of kidney disease. His research work focuses on elucidating
the genetics of glomerular diseases (particularly IgA nephropathy, HIV
associated nephropathy) and renal and urologic developmental abnormalities.
Dr. Gharavi is recipient of Irving Clinical Scholar Award from Columbia
University, the 2004 Judson Daland Prize for Outstanding Achievement in
Clinical Investigations from the American Philosophical society and the
2005 Clinical Scientist Award from the National Kidney Foundation. He is also on the editorial board of the
Journal of the American Society of Nephrology
|
|
Michael
Barry Stokes, M.D.
Dr. Stokes is an Assistant Professor of Clinical Pathology. He obtained his
medical degree in Dublin, Ireland, and completed pathology residency at New
York University Medical Center. This was followed by renal pathology
fellowship training at the University of Washington, Medial Center in
Seattle, where Dr Stokes was the recipient of a National Kidney Foundation
Research Fellowship Grant. Prior to joining the Renal Pathology Division at
Columbia University Medical Center in 2002, Dr. Stokes directed the Renal
Pathology Laboratory at New York University Medical Center. He has authored
or co-authored twenty manuscripts, mainly focused on clinical-pathologic
correlations in glomerular disease
|
|
Jonathan Barasch, M.D.
Dr. Barasch MD PhD was trained in the field of cell biology in the
laboratories of Michael D. Gershon, Chairman Department of Anatomy and Cell
Biology and Qais Al-Awqati, Chief, Division of Nephrology. He was also
trained in nephrology by Gerald Appel, Chief, Clinical Neprology and is
board certified in medicine and nephrology. He is on the editorial board of
the American Journal of Physiology and a member of the American Society for
Clinical Investigation. His group has isolated the first molecules to cause
glomeruli to form from fetal cells and, conversely, is identifying a
molecule that inhibits the formation of glomeruli. He is also investigating
a regulator that proportions the cells of the glomerulus. His other major
accomplishment is the isolation of the progenitor cell that gives rise to
the glomerulus.
|
|
Pietro Canetta, M.D., M.Sc.
Dr. Canetta is an Assistant Professor of Clinical Medicine. A native of
Milan, Italy, he completed his undergraduate training at Yale University
and his medical degree at Columbia University, where he was elected to the
Alpha Omega Alpha honor society. He remained at CUMC/NYP for specialty and
subspecialty training, and during residency received awards for for
housestaff teaching, outpatient clinic, and critical care service. He
obtained a Masters of science in Biostatistics from the Mailman School of
Public Health, and completed post-specialization clinical training through
the Fellowhsip in Glomerular Diseases at Columbia University. Dr. Canetta
has published on a spectrum of glomerular diseases and has served as
co-investigator on several clinical trials. He enjoys teaching medical
students, residents and nephrology fellows, and his research interests
include IgA nephropathy and the nephrotic syndrome.
|
|
|
|
|